Roy Jakobs

Roy will be appointed as an Independent Non-Executive Director on 13 July 2026.

Roy has extensive global executive leadership experience in the health technology sector, with exposure in innovative adjacent technologies to biopharmaceuticals including patient monitoring, imaging and intervention. Roy’s values and approach to culture and purpose are highly aligned with GSK’s, and he brings significant strategic insight and leadership experience to the Board.

Roy has served as CEO of Royal Philips since 2022. Prior to that, he held international roles of increasing seniority after joining the company in 2010. He has also held senior roles at other global companies including Shell and Elsevier, and holds a Master's in Business Administration (MBA).

External appointments

• CEO, Koninklijke Philips N.V. (Royal Philips)